Founded in 2023, Microworld Biotech Private Limited is driven by a clear mission: to advance diagnostic solutions that are faster, more accessible, and highly reliable—for the benefit of mankind.
Established by seasoned professionals with deep expertise in pharmaceuticals and healthcare, the company is built on a practical understanding of real-world diagnostic challenges. Traditional laboratory testing often relies on complex infrastructure, specialized skills, and longer turnaround times, while many rapid tests struggle to deliver the accuracy and clinical confidence required.
Microworld Biotech was created to bridge this gap.
As a focused B2B partner, we develop and deliver advanced diagnostic solutions that combine speed, precision, and ease of use. Our portfolio is designed to support healthcare providers, laboratories, and partners across the value chain, enabling efficient and dependable testing in both advanced clinical settings and resource-limited environments.
Guided by a strong commitment to quality, innovation, and accessibility, we aim to make reliable diagnostics available where they are needed most—contributing to better healthcare outcomes and improving lives globally.
Today, Microworld Biotech is steadily growing as a trusted partner in the IVD ecosystem, delivering scalable solutions that serve both industry needs and the broader goal of advancing healthcare for mankind.
At Microworld Biotech, technology is at the core of everything we do.
We utilize advanced Immunochromatography technology, designed to deliver fast and reliable diagnostic results.
By combining scientific innovation with practical usability, our technology bridges the gap between laboratory-grade accuracy and real-world accessibility.
Our work is guided by a strong set of values that define how we operate and what we stand for:
We continuously invest in research and development to bring next-generation diagnostic solutions to the market.
We are committed to delivering highly precise and dependable results that healthcare professionals can trust.
We believe quality healthcare should be available to everyone, including those in remote and underserved regions.
Our solutions are designed to be cost-effective without compromising on quality.
We support our partners with training, after-sales service, and consistent supply to ensure smooth operations.

Our Dengue Combo Test Kit is an advanced rapid diagnostic solution designed for the qualitative detection of Dengue NS1 antigen and IgG/IgM antibodies in human serum or plasma. It enables early and accurate diagnosis, supporting timely clinical decisions and effective patient management.

The MicroWorld Malaria Pf/Pv Antigen Test is a high-sensitivity rapid diagnostic test (RDT) designed for the qualitative detection and differentiation of malaria infections. Utilizing advanced chromatographic immunoassay technology, this kit allows healthcare providers to distinguish between Plasmodium falciparum and Plasmodium vivax directly from a human blood sample.

Our Typhoid IgG/IgM Rapid Test Kit is a high-performance diagnostic solution designed for the simultaneous detection and differentiation of IgG and IgM antibodies to Salmonella typhi in human serum or plasma. It enables quick screening and supports timely clinical decision-making.

The MummySure Pregnancy hCG Detection Test Kit is a rapid diagnostic tool designed for the early and accurate detection of pregnancy.